Firm to conduct U.S. trial of dialysis device before year's end

11/22/2013 | American City Business Journals

Ambler, Pa.-based Bioconnect Systems is set to launch a U.S. clinical trial evaluating its OptiFlow system before the close of 2013. The technology is designed to enhance vascular access for patients undergoing dialysis by creating precisely controlled surgical connections that link a patient's vein to an artery.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC